Literature DB >> 12183313

Systematic reviews and lifelong diseases.

Heather E Elphick1, Anton Tan, Deborah Ashby, Rosalind L Smyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183313      PMCID: PMC1123891          DOI: 10.1136/bmj.325.7360.381

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  19 in total

1.  Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention.

Authors:  K Cheng; R L Smyth; J Motley; U O'Hea; D Ashby
Journal:  Pediatr Pulmonol       Date:  2000-01

2.  Further comments on fibrosing colonpathy study.

Authors:  A Mehta
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

Review 3.  Assessment of therapeutic safety in systematic reviews: literature review.

Authors:  E Ernst; M H Pittler
Journal:  BMJ       Date:  2001-09-08

4.  Effects of chronic tobramycin treatment on distortion product otoacoustic emissions.

Authors:  B Katbamna; D N Homnick; J H Marks
Journal:  Ear Hear       Date:  1999-10       Impact factor: 3.570

5.  Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen.

Authors:  C S Scott; G Z Retsch-Bogart; M M Henry
Journal:  Pediatr Pulmonol       Date:  2001-04

6.  Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.

Authors:  R Padoan; W Cambisano; D Costantini; R M Crossignani; M L Danza; G Trezzi; A Giunta
Journal:  Pediatr Infect Dis J       Date:  1987-07       Impact factor: 2.129

7.  Aminoglycoside induced ototoxicity in patients with cystic fibrosis.

Authors:  D Mulherin; J Fahy; W Grant; M Keogan; B Kavanagh; M FitzGerald
Journal:  Ir J Med Sci       Date:  1991-06       Impact factor: 1.568

8.  Investigation of aminoglycoside nephrotoxicity in cystic fibrosis patients.

Authors:  C Godson; M P Ryan; D O'Halloran; S Bourke; H R Brady; M X FitzGerald
Journal:  Scand J Gastroenterol Suppl       Date:  1988

9.  Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.

Authors:  F J McLaughlin; W J Matthews; D J Strieder; B Sullivan; A Taneja; P Murphy; D A Goldmann
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

10.  Cystic fibrosis: antibiotic prescribing practices in the United Kingdom and Eire.

Authors:  R F Taylor; M E Hodson
Journal:  Respir Med       Date:  1993-10       Impact factor: 3.415

View more
  7 in total

1.  Acute renal failure in people with cystic fibrosis.

Authors:  Kevin W Southern
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

2.  Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data?

Authors:  Michael Bauer; Natalie Rasgon; Paul Grof; Laszlo Gyulai; Tasha Glenn; Peter C Whybrow
Journal:  MedGenMed       Date:  2005-08-25

Review 3.  Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence.

Authors:  Stephanie J C Taylor; Bridget Candy; Rosamund M Bryar; Jean Ramsay; Hubertus J M Vrijhoef; Glenda Esmond; Jadwiga A Wedzicha; Chris J Griffiths
Journal:  BMJ       Date:  2005-08-10

Review 4.  Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.

Authors:  Heather E Elphick; Alison Scott
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

Review 5.  Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.

Authors:  S L Norris; X Zhang; A Avenell; E Gregg; C H Schmid; J Lau
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

6.  Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis.

Authors:  J Thornton; R Elliott; M P Tully; M Dodd; A K Webb
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

7.  Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.

Authors:  Poppy Holland; Nikki Jahnke
Journal:  Cochrane Database Syst Rev       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.